Suchergebnisse - "Walker, Gareth J"

PubPharm (20)

1

Prevalence of NUDT15 Genetic Variants and Incidence of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease : A Systematic Review and Meta-analysis

enthalten in: Journal of Crohn's & colitis | 2023

von Yu, N. | Sriranganathan, D. | Walker, G. | +8

2

Massive parallel variant characterization identifiesNUDT15alleles associated with thiopurine toxicity

enthalten in: bioRxiv.org | 2023

von Suiter, C. | Moriyama, T. | Matreyek, K. | +28

3

Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic : the PREPARE-IBD multicentre cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Saifuddin, A. | Kent, A. | Mehta, S. | +113

CommentIn: Aliment Pharmacol Ther. 2023 Jan;57(1):156-157. - PMID 36468219

4

Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease : results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Chanchlani, N. | Lin, S. | Auth, M. | +99

CommentIn: Aliment Pharmacol Ther. 2022 Oct;56(8):1294-1295. - PMID 36168263

5

Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients

enthalten in: Journal of Crohn's & colitis | 2022

von Ricciuto, A. | Lamb, C. | Benchimol, E. | +12

6

Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients : insights from a multicentre UK cohort study

enthalten in: BMJ open gastroenterology | 2022

von Sebastian, S. | Patel, K. | Segal, J. | +13

7

Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID‐19 pandemic : the PREPARE‐IBD multicentre cohort study

enthalten in: Alimentary Pharmacology & Therapeutics | 2022

von Saifuddin, A. | Kent, A. | Mehta, S. | +12

8

Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease : results from the IMmunogenicity to Second Anti‐TNF therapy ( IMSAT) therapeutic drug monitoring study

enthalten in: Alimentary Pharmacology & Therapeutics | 2022

von Chanchlani, N. | Lin, S. | Auth, M. | +98

9

Letter : risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Lamb, C. | Sebastian, S. | Kent, A. | +12

CommentOn: Aliment Pharmacol Ther. 2020 Jul;52(2):276-283. - PMID 32359205

10

Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC) : a multicentre, observational, case-control study

enthalten in: The lancet. Gastroenterology & hepatology | 2021

von Sebastian, S. | Walker, G. | Kennedy, N. | +112

CommentIn: Lancet Gastroenterol Hepatol. 2021 Apr;6(4):254-255. - PMID 33545082